Download PDF
Thromb Haemost 1995; 74(01): 077-080
DOI: 10.1055/s-0038-1642656
Symposium
Platelets,Prostaglandins,Lipids,NO
Schattauer GmbH Stuttgart

Thrombin Generation in Myocardial Infarction and Hypercholesterolemia: Effects of Aspirin

Andrzej Szczeklik
Department of Medicine, University School of Medicine, Cracow, Poland
› Author Affiliations
Further Information

Publication History

Publication Date:
09 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Swords NA, Mann KG. The assembly of the prothrombinase complex cm adherent platelets. Arterioscl Thromb 1993; 13: 1602-1612
    CrossrefPubMedGoogle Scholar
  • 2 Szczeklik A, Musial J, Dropinski J, Krzanowski M, Krolikowski W, Undas A, Swadzba J, Duplaga M, Bodzon W. Thrombinogenesis and its pharmacological modulation in atherosclerosis. J Physiol Pharmacol 1994; 45: 3-11
    PubMedGoogle Scholar
  • 3 Rugman FP, Jenkins JA, Duguid JK, Maggs PB, Hay CR M. Prothrombin fragment Fl+ 2: correlations with cardiovascular risk factors. Blood Coagul Fibrin 1994; 5: 335-340
    PubMedGoogle Scholar
  • 4 Giansante C, Fiotti N, Cattin L, Da Col PG, Calabrese S. Fibrinogen, D- dimerand thrombin-antithrombin complexes in a random population sample: Relationships with other cardiovascular risk factors. Thromb Haemost 1994; 71: 581-586
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Pitney WR, Dacie JV. A simple method for studying the generation of thrombin in recalcified plasma. J Clin Pathol 1953; 6: 9-15
    CrossrefPubMedGoogle Scholar
  • 6 Szczeklik A. Generation of the proteolytic activity bound with alpha2macroglobulin during plasma clotting. Clin Chim Acta 1970; 27: 339-348
    CrossrefPubMedGoogle Scholar
  • 7 Hemker HC, Wielders S, Kessels H, Beguin S. Continuous registration of thrombin generation in plasma, its use for the determination of the thrombin potential. Thromb Haemost 1993; 70: 617-624
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Bendetowicz AV, Hu Kai, Knebel R, Caplain H, Hemker C, Lindhout T, Beguin S. The effect of subcutaneous injection of unfractionated and low molecular weight heparin on thrombin generation in platelet rich plasma - a study in human volunteers. Thromb Haemost 1994; 72: 705-712
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Brommer EJ P, Meijer P. Thrombin generation induced by the intrinsic or extrinsic coagulation pathway is accelerated by streptokinase, independently of plasminogen. Thromb Haemost 1993; 70: 995-997
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Galhstl S, Muntean W. Thrombin-hirudin complex formation, thrombin- antithrombin III complex formation, and thrombin generation after intrinsic activation of plasma. Thromb Haemost 1994; 72: 387-392
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Ratnatunga CP, Edmondson SF, Rees GM, Kovacs IB. High-dose aspirin inhibits shear-induced platelet reaction involving thrombin generation. Circulation 1992; 85: 1077-1082
    CrossrefPubMedGoogle Scholar
  • 12 Thomgren M, Shafi S, Bom GV R. Thromboxane A2 in skin-bleeding time blood and in clotted venous blood before and after administration of acetyl- salicylic acid. Lancet 1983; 1: 1075-1078
    CrossrefPubMedGoogle Scholar
  • 13 Kyrle PA, Westwick J, Scully MF, Kakkar VV, Levis GP. Investigation of the interaction of blood platelets with the coagulation system at the site of plug formation ex vivo in man - effect oflow-dose aspirin. Thromb Haemost 1987; 57: 62-69
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 Weiss HI, Lages B. Evidence for tissue factor-dependent activation of the classic extrinsic coagulation mechanism in blood obtained from bleeding time wounds. Blood 1988; 71: 629-635
    PubMedGoogle Scholar
  • 15 Szczeklik A, Krzanowski M, Gora P, Radwan J. Antiplatelet drags and generation of thrombin in clotting blood. Blood 1992; 80: 2006-2011
    CrossrefPubMedGoogle Scholar
  • 16 Szczeklik A, Dropinski J, Gora P. Serum immunoglobulin E and sudden cardiac arrest during myocardial infarction. Coronary Artery Dis 1993; 4: 1029-1032
    CrossrefPubMedGoogle Scholar
  • 17 Eisenberg PR, Sherman LA, Jaffe AS. Paradoxic elevation of fibrinopeptide A after streptokinase: Evidence for continued thrombosis despite intense fibrinolysis. J Am Coll Cardiol 1987; 10: 527-529
    CrossrefPubMedGoogle Scholar
  • 18 Owen J, Friedman KD, Grossman BA, Wilkins C, Berke AD, Powers ER. Thrombolytic therapy with tissue plasminogen activator or streptokinase induces transient thrombin activity. Blood 1988; 72: 616-620
    PubMedGoogle Scholar
  • 19 Rapold HJ, de Bono D, Arnold AE R, Amout J, de Cock F, Collen D, Verstraete M. Plasma fibrinopeptide A levels in patients with acute myocardial infarction treated with alteplase. Correlation with concomitant heparin, coronary artery patency, and recurrent ischemia. Circulation 1992; 85: 928-934
    CrossrefPubMedGoogle Scholar
  • 20 Garabedian HD, Gold HK, Newell IB, Collen D, Hagstrom JN, Bovill EG. Accelerated thrombin generation during anticoagulation in patients with unstable angina pectoris. Blood 1994; 83: 1155-1158
    PubMedGoogle Scholar
  • 21 ISIS-2 Colleborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected myocardial infarction. Lancet 1988; 2: 349-360
    PubMedGoogle Scholar
  • 22 The RAPT Investigators. Randomized trial of ridogrel, a combined thromboxane A2 synthase inhibitor and thromboxane A2 / Prostaglandin endoperoxids receptor antagonist, versus aspirin as adjunct to thrombolysis in patients with acute myocardial infarction. Circulation 1994; 89: 588-595
    CrossrefPubMedGoogle Scholar
  • 23 Szczeklik A, Dropinski J, Radwan J, Krzanowski M. Presistent generation of thrombin after acute myocardial infarction. Arterioscl Thromb 1992; 12: 548-553
    CrossrefPubMedGoogle Scholar
  • 24 Merlini PA, Bauer KA, Oltrona L, Ardissino D, Cattaneo M, Belli C, Mannucci PM, Rosenberg RD. Presistent activation of coagulation mechanism in unstable angina and myocardial infarction. Circulation 1994; 90: 61-68
    CrossrefPubMedGoogle Scholar
  • 25 Szczeklik A, Milner PC, Birch J, Watkins J, Martin JF. Prolonged bleeding time, reduced platelet aggregation, altered PAF-acether sensitivity and increased platelet mass are a trait of asthma and hay fever. Thromb Haemost 1986; 56: 283-287
    Article in Thieme ConnectPubMedGoogle Scholar
  • 26 Szczeklik A, Schmitz-Schumann M, Krzanowski M, Virchow C. Delayed generation of thrombin in clotting blood of atopic patients with hay fever and asthma. Clin Exp Allergy 1991; 21: 411-415
    CrossrefPubMedGoogle Scholar
  • 27 Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990 323: 27-36
    PubMedGoogle Scholar
  • 28 Patrono C. Aspirin as an antiplatelet drug. N Engl J Med 1994; 330: 1287-1294
    CrossrefPubMedGoogle Scholar
  • 29 Watala C, Gwozdzinski K. Effect of aspirin on conformation and dynamics of membrane proteins in platelets and erythrocytes. Biochem Pharmacol 1993; 45: 1343-1349
    CrossrefPubMedGoogle Scholar
  • 30 Szczeklik A, Musial J, Undas A, Swadzba J, Gora P, Duplaga M. Aspirin inhibits thrombinogenesis in normocholesterolemic but not in hypercholesterolemic man. Thromb Haemost 1993; 69: 798
    PubMedGoogle Scholar
  • 31 Grotemeyer KH. Schorafinski HW. Husstedt IW. 2-year follow-up of aspirin responder and aspirin non-responder - a pilot study including 180 post-stroke patients. Thromb Res 1993; 71: 397-403
    CrossrefPubMedGoogle Scholar
  • 32 De Lorgeril M, Dureau G, Boissonat P, Ovize M, Monnez C, Monjaud I, Salen P, Renaud S. Increased platelet aggregation afterheart transplantation: influence of aspirin. J Heart Lung Tmasplant 1991; 10: 600-603
    PubMedGoogle Scholar
  • 33 Davi G, Avema M, Catalano I, Baibagallo C, Ganci A, Notarbartalo A, Ciabattoni G, Patrono C. Increased thromboxane biosynthesis in type Ha hypercholesterolemia. Circulation 1992; 85: 1792-1798
    CrossrefPubMedGoogle Scholar
  • 34 Basili S, Maurelli M, Bracaglia D, Massafra S, Pergolini M, Cancrini C, Cara D, Vieri M, Alessandri C, Cordova C. Hypercoagulability state in patients with polygenic hypercholesterolemia. Eur Heart J 1994; 15 (suppl.) 311
    CrossrefPubMedGoogle Scholar